CORT News

Pomerantz LLP Reminds Shareholders with Losses on their Investment in Corcept Therapeutics Incorporated – CORT

CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Approaching April 21st Lead Plaintiff Deadline in Securities Fraud Class Action Over Relacorilant Failure

Pomerantz LLP Reminds Investors: Securities Lawsuit Has Been Filed Against Corcept Therapeutics Incorporated – CORT

CORT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Corcept Therapeutics Incorporated Shareholders Have Opportunity to Lead Class Action Lawsuit!

Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

CORT DEADLINE NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Corcept Therapeutics Incorporated Investors with Losses in Excess of $100K to Secure Counsel Before Important April 21 Deadline in Securities Class Action - CORT

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines – CORT

Lifshitz Law PLLC Announces Investigations of Corcept Therapeutics, Inc. (NASDAQ: CORT), NuScale Power Corporation (NYSE: SMR), PayPal Holdings, Inc. (NASDAQ: PYPL), and Enphase Energy, Inc. (NASDAQ: ENPH)

Corcept (CORT) Class Action Alleges Misstatements on FDA Data Concerns - Hagens Berman